Table 4 Characteristics and endoscopic findings of patients diagnosed with gastric adenocarcinoma at index EGD
With gastric adenocarcinoma on index EGD (n = 18) | |
|---|---|
Male, n (%) | 11 (61.1%) |
Age at index EGD, median (IQR) | 71 (64 – 74) |
Smoking history, n (%) | |
Never | 8 (44.4%) |
Current | 3 (16.7%) |
Former | 7 (38.9%) |
History of GERD | 7 (38.9%) |
History of H. pylori infection | 1 (5.5%) |
Family history of 1st degree relative with cancer | |
No family history | 12 (66.7%) |
Gastric cancer | 0 (0.0%) |
Non-gastric GI cancer | 5 (27.8%) |
Other cancer | 1 (5.5%) |
Hemoglobin at time of index EGD, median (IQR) | 12.7 (10.9 – 13.9) |
Indication for index EGD (Top 5) | |
Abdominal pain | 8 (44.4%) |
Weight loss or constitutional symptoms | 7 (38.9%) |
Abnormality on non-invasive imaging | 6 (33.3%) |
Early satiety or bloating | 5 (27.8%) |
GI bleeding | 3 (16.7%) |
Iron deficiency anemia | 3 (16.7%) |
Location of endoscopic abnormality observed at index EGD | |
No abnormalities | 0 (0.0%) |
Antrum | 9 (50.0%) |
Body | 3 (16.7%) |
Pylorus | 1 (5.5%) |
Cardia | 1 (5.5%) |
Fundus | 4 (22.2%) |
Generalized | 1 (5.5%) |
Angularis | 0 (0.0%) |
Type of endoscopic abnormality observed at index EGD | |
Erythema | 2 (11.1%) |
Nodularity | 5 (27.8%) |
Erythema and erosions | 0 (0.0%) |
Atrophic/decreased folds | 3 (16.7%) |
Gastropathy, not otherwise specified | 3 (16.7%) |
Ulcer | 3 (16.7%) |
Thickened folds | 1 (5.5%) |
Mottled appearance | 4 (22.2%) |
Othera | 6 (33.3%) |